NT5E and ovarian cancer: The analysis revealed that high CD73 expression was significantly associated with decreased OS in breast cancer (HR = 1.23) and ovarian cancer (HR = 1.14), while it correlated with favourable OS in lung cancer (HR = 0.80) and gastric cancer (HR = 0.71).